Vision 1 Year after Gene Therapy for Leber's Congenital Amaurosis

  • Cideciyan A
  • Hauswirth W
  • Aleman T
  • et al.
192Citations
Citations of this article
88Readers
Mendeley users who have this article in their library.

Abstract

Curcumin, a natural diphenolic compound derived from turmeric Curcuma longa, has proven to be a modulator of intracellular signaling pathways that control cancer cell growth, inflammation, invasion and apoptosis, revealing its anticancer potential. In this review, we focus on the design and development of nanoparticles, self-assemblies, nanogels, liposomes and complex fabrication for sustained and efficient curcumin delivery. We also discuss the anticancer applications and clinical benefits of nanocurcumin formulations. Only a few novel multifunctional and composite nanosystem strategies offer simultaneous therapy as well as imaging characteristics. We also summarize the challenges to developing curcumin delivery platforms and up-to-date solutions for improving curcumin bioavailability and anticancer potential for therapy.

Cite

CITATION STYLE

APA

Cideciyan, A. V., Hauswirth, W. W., Aleman, T. S., Kaushal, S., Schwartz, S. B., Boye, S. L., … Jacobson, S. G. (2009). Vision 1 Year after Gene Therapy for Leber’s Congenital Amaurosis. New England Journal of Medicine, 361(7), 725–727. https://doi.org/10.1056/nejmc0903652

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free